Drug Safety in the Modern Age: Is it Time for a Larger-scale Revamp of Adverse Event Case Processing?
The overall architecture of pharmacovigilance (PV) has changed very little over the last couple of decades. As AI-driven process automation advances from theoretical possibility to…
Read More